Eli Lilly and Company

Eli Lilly Misses on EPS, Stock Down 2.72%

Eli Lilly's earnings report showed a slight miss on EPS, which led to a 2.72% decline in the stock price. Investors may be concerned about the company's performance, especially since no revenue figures or guidance updates were provided. The lack of additional context from management could contribute to uncertainty among investors.